Evonik Industries

Evonik Industries AG, headquartered in Germany, is a global specialty chemicals company. It operates in four major segments: specialty additives, smart materials, nutrition and care, and performance materials. Evonik produces and markets chemicals used in diverse industries, from automotive to pharmaceuticals, offering innovative solutions in areas such as animal nutrition, additives, smart materials, health care, and high-performance polymers. The company is a market leader in approximately 80% of its businesses and has a significant presence in Europe, North America, and Asia. Evonik Venture Capital, its corporate venture arm, invests in startups and venture capital funds with innovative technologies and high growth potential, focusing on areas such as resource efficiency, specialty additives, health & care, and nutrition.

Jens Busse

Investment Director

Lars Bönisch

Venture Capitalist

Erning Cao

Investment Director

Thomas Grosse-Puppendahl

Vice President, Operations

Jonas Ide

Investment Manager

Christian Kullmann

Chairman

Bernhard Mohr

Managing Director

Wolfgang Nestel

Investment Director

Franziska Schlumprecht

Investment Manager

Lutz Stoeber Ph.D

Investment Director and Head of Venture Capital and Investments, North America

58 past transactions

Abolis Biotechnologies

Venture Round in 2024
Abolis is a French company delivering high-impact innovations in biotechnologies that supports industries in their transition to build a better future in collaboration with Nature. We provide tailor-made industrial solutions based on micro-organisms. Founded in 2014, Abolis is made up of a team of over 54 people, sharing a scientific and humanist ambition. Determined to become a key player in the transformation of manufacturing, we combine our expertise in biology, fermentation, IT, robotics, analytics and industrial property to reinvent the future of numerous industries - from food to healthcare, cosmetics and chemicals. We help industries make the ecological transition by rethinking their production models We rely on biotechnologies and the untapped potential of micro-organisms to develop new bioproduction solutions that are economically and ecologically sustainable alternatives to petrochemical products and chemical ingredients. We take up the industry's current challenges by: · Using renewable raw materials · Relocate essential production and secure supply chains · Designing biocompatible products less toxic for the environment · Reducing greenhouse gas emissions Abolis is providing tailor-made industrial solutions, based on microorganisms We are… independent in thought and action rigorous in our approach and the way we work creative because we never stop innovating, while remaining pragmatic ambitious because we are passionate and determined to make a difference

Strohm

Venture Round in 2024
Strohm is a private supply chain company specializing in the offshore wind-to-hydrogen sector. It manufactures fully bonded, thermoplastic composite pipes designed for various applications in the offshore oil and gas industry. Strohm's product offerings include downlines, well intervention hoses, jumpers, spools, offshore flowlines, and risers. These composite pipes are lightweight, high-strength, and corrosion-resistant, providing significant cost and operational advantages for clients engaged in subsea intervention and production activities. Through its innovative solutions, Strohm aims to enhance efficiency and reliability in the energy sector.

Velox

Venture Round in 2024
Velox develops and manufactures industrial-grade direct-to shape digital decoration solutions for the rigid container industry. Their proprietary DTS-Inkjet technology, based on uniquely formulated inks and dedicated deposition architecture, introduces an entirely new approach to digital printing that is poised to disrupt the packaging decoration market. Their debut product is the Velox IDS 250 – the first industrial-grade digital decorator for mass production of cylindrical containers available on the market. It delivers superior decoration quality and capabilities that outstrip analog printing solutions, while allowing a more efficient and flexible production process and a low total cost of ownership (TCO). Velox is powered by an expert team with uniquely extensive and wide-ranging experience in digital printing. It is led by veteran executives with proven success in driving company growth.

JLand Biotech

Series B in 2023
JLand Biotech specializes in the development and manufacturing of Biollagen™, a non-animal sourced collagen produced through advanced bioengineering techniques like genetic recombination and microbial fermentation. The company aims to become the world's leading supplier of non-animal collagen, catering primarily to industries such as cosmetics and food.

HPNow

Series A in 2023
HPNow is a company focused on developing innovative water and air treatment solutions through the on-site generation of hydrogen peroxide. Their technology allows for the efficient and autonomous production of hydrogen peroxide using only water, electricity, and air. With their compact HPGen hydrogen-peroxide generators, HPNow aims to replace conventional disinfectants, such as chlorine, which are increasingly regulated due to safety concerns. This transition not only enhances the safety of water, air, and food but also offers significant cost savings and logistical benefits for users. By providing a safer and eco-friendly alternative to toxic chemical disinfectants, HPNow seeks to reduce environmental impact while improving overall treatment efficacy across various industries.

Novacem

Acquisition in 2023
Novacem Limited is a London-based company focused on developing a carbon-negative cement made from magnesium oxide and hydrated magnesium carbonates. This innovative approach aims to transform the cement industry, traditionally known for its significant carbon dioxide emissions, into a sector that can absorb CO2. By leveraging advanced materials science, Novacem seeks to provide sustainable alternatives to conventional cement, addressing environmental concerns while maintaining functionality in construction applications.

SuperC

Venture Round in 2023
SuperC is a company founded in 2012 and based in Dongguan City, Guangdong, China, specializing in the research and production of innovative nanomaterials. It develops Few Layer Graphenes (FLG), which are utilized in a variety of applications, including lithium-ion batteries, fireproof coatings, anticorrosive coatings, and materials that enhance electrical and thermal conductivity. Through its focus on advanced nanotechnology, SuperC aims to contribute to sectors that require high-performance materials, positioning itself as a key player in the nanomaterials market.

Strohm

Venture Round in 2022
Strohm is a private supply chain company specializing in the offshore wind-to-hydrogen sector. It manufactures fully bonded, thermoplastic composite pipes designed for various applications in the offshore oil and gas industry. Strohm's product offerings include downlines, well intervention hoses, jumpers, spools, offshore flowlines, and risers. These composite pipes are lightweight, high-strength, and corrosion-resistant, providing significant cost and operational advantages for clients engaged in subsea intervention and production activities. Through its innovative solutions, Strohm aims to enhance efficiency and reliability in the energy sector.

Allay Therapeutics

Series C in 2022
Allay Therapeutics is focused on developing innovative solutions for post-surgical pain management, aiming to enhance patient recovery experiences. The company utilizes a proprietary technology platform that integrates validated non-opioid analgesics with biopolymers to create dissolvable therapeutics. These products are designed to deliver targeted pain relief over extended periods, significantly surpassing the duration of existing pain treatments. Allay's lead investigational product, ATX101, is currently undergoing evaluation in a Phase 2 clinical study for total knee arthroplasty surgeries. With a diverse team of entrepreneurs, scientists, and clinicians based in the San Francisco Bay Area and Singapore, Allay Therapeutics seeks to address the limitations of conventional pain management approaches, particularly the challenges associated with opioid use.

Strohm

Venture Round in 2022
Strohm is a private supply chain company specializing in the offshore wind-to-hydrogen sector. It manufactures fully bonded, thermoplastic composite pipes designed for various applications in the offshore oil and gas industry. Strohm's product offerings include downlines, well intervention hoses, jumpers, spools, offshore flowlines, and risers. These composite pipes are lightweight, high-strength, and corrosion-resistant, providing significant cost and operational advantages for clients engaged in subsea intervention and production activities. Through its innovative solutions, Strohm aims to enhance efficiency and reliability in the energy sector.

Vivasure Medical

Series D in 2022
Vivasure Medical Limited is a medical device company based in Galway, Ireland, that specializes in the research, development, and manufacture of arterial and venous closure devices utilizing its patented PerQseal technology. The company focuses on creating polymer implants and delivery systems aimed at minimally invasive vessel closures, primarily in cardiology, interventional radiology, and vascular surgery. Its flagship product is an absorbable patch-based large-bore percutaneous closure device, designed to effectively close large arteriotomies resulting from transcatheter procedures, including transcatheter aortic valve replacement and endovascular aneurysm repair. Founded in 2008, Vivasure Medical is committed to advancing techniques that enhance patient outcomes in vascular access procedures.

In Ovo

Series B in 2022
In Ovo is a biotechnology company focused on enhancing animal welfare and operational efficiency within the poultry industry. It addresses a significant issue in hatcheries: the culling of male chicks shortly after hatching. The company has developed an innovative gender screening technology that utilizes biomarkers to identify the gender of embryos early in the breeding process. This solution alleviates the stress associated with traditional manual gender sorting, reduces energy consumption and carbon dioxide emissions in hatcheries, and eliminates the necessity to cull one-day-old male chicks. By improving animal welfare and promoting sustainability, In Ovo aims to transform the practices within the poultry sector while simultaneously increasing efficiency.

Shanghai Union Technology

Series D in 2021
Shanghai Union Technology is an additive manufacturing company that operates in the field of industrial 3D printing. UnionTech adds value to users and improves their experiences through 3D printing technology based on 3D digital manufacturing. The company improves actual production efficiency while reducing reliance on field production personnel and truly realizing refined production process management.

UnionTech 3D

Series D in 2021
UnionTech 3D specializes in stereolithography 3D printing, an additive manufacturing technology that enables the production of highly precise and detailed polymer parts. The company develops industrial-grade 3D printers tailored for various sectors, including manufacturing, automotive, aerospace, and medical industries. In addition to manufacturing equipment, UnionTech 3D emphasizes research and development to enhance its product offerings. The company also provides technical support to facilitate the integration of 3D printing into industrial production processes.

Castor Technologies

Seed Round in 2021
Castor Technologies, established in 2017 and based in Tel Aviv, Israel, specializes in developing 3D printing software. This software connects manufacturers with 3D printing capabilities, aiding them in evaluating how to integrate industrial 3D printing into their production processes. By offering a detailed technical and cost-saving analysis for an entire bill of materials, Castor empowers designers, new product introduction managers, and production engineers to make informed decisions when producing machine parts.

JeNaCell

Acquisition in 2021
JeNaCell GmbH, founded in 2012 and based in Jena, Germany, specializes in biotechnology, focusing on the development and manufacture of bio-technologically derived cellulose. The company has created a patented technology for the continuous production of high-performance biomaterials featuring natural nanostructures. This innovative nano cellulose is characterized by its defined shape and controllable structural design, allowing clients to develop advanced products in medicine, cosmetics, technology, and pharmaceuticals. JeNaCell's offerings aim to enhance skin protection, particularly in the treatment of chronic wounds, and support applications in laser treatments and aesthetic dermatology.

In Ovo

Venture Round in 2021
In Ovo is a biotechnology company focused on enhancing animal welfare and operational efficiency within the poultry industry. It addresses a significant issue in hatcheries: the culling of male chicks shortly after hatching. The company has developed an innovative gender screening technology that utilizes biomarkers to identify the gender of embryos early in the breeding process. This solution alleviates the stress associated with traditional manual gender sorting, reduces energy consumption and carbon dioxide emissions in hatcheries, and eliminates the necessity to cull one-day-old male chicks. By improving animal welfare and promoting sustainability, In Ovo aims to transform the practices within the poultry sector while simultaneously increasing efficiency.

Chembid

Venture Round in 2021
Chembid is a metasearch platform that facilitates the efficient discovery of chemical raw materials online. Targeting professionals in the chemical industry such as chemists, formulators, and commercial buyers, Chembid provides a user-friendly tool for precisely locating the necessary materials for various applications, including coatings and adhesives. The platform also enhances visibility for chemical suppliers and manufacturers by showcasing their products to a broader audience. Chembid's foundation lies in its comprehensive and reliable product data, which supports digital matchmaking at the moment of demand from buyers across the industrial chemicals market. By combining extensive market information with deep data analysis, Chembid enables users to conduct automated market and product analyses, ultimately aiding in business growth for both buyers and sales professionals in the chemical sector.

UnionTech 3D

Venture Round in 2020
UnionTech 3D specializes in stereolithography 3D printing, an additive manufacturing technology that enables the production of highly precise and detailed polymer parts. The company develops industrial-grade 3D printers tailored for various sectors, including manufacturing, automotive, aerospace, and medical industries. In addition to manufacturing equipment, UnionTech 3D emphasizes research and development to enhance its product offerings. The company also provides technical support to facilitate the integration of 3D printing into industrial production processes.

HPNow

Seed Round in 2020
HPNow is a company focused on developing innovative water and air treatment solutions through the on-site generation of hydrogen peroxide. Their technology allows for the efficient and autonomous production of hydrogen peroxide using only water, electricity, and air. With their compact HPGen hydrogen-peroxide generators, HPNow aims to replace conventional disinfectants, such as chlorine, which are increasingly regulated due to safety concerns. This transition not only enhances the safety of water, air, and food but also offers significant cost savings and logistical benefits for users. By providing a safer and eco-friendly alternative to toxic chemical disinfectants, HPNow seeks to reduce environmental impact while improving overall treatment efficacy across various industries.

Porocel International

Acquisition in 2020
Porocel International specializes in manufacturing activated alumina, inert bed supports, and specialty adsorbents, primarily serving the refining and petrochemical industries. Founded in 1937 and headquartered in Houston, Texas, the company produces a range of products including activated bauxite and aluminum oxide, as well as catalyst regeneration services. In addition to manufacturing, Porocel offers various toll processing services such as calcination, drying, forming, impregnation, size reduction, and classification. The company operates manufacturing sites and offices across North America, Europe, and Southeast Asia, along with catalyst service facilities in these regions. As of November 2020, Porocel operates as a subsidiary of Evonik Industries AG.

Element

Series B in 2020
Element Analytics, Inc. is a developer of industrial analytics software that transforms raw data into actionable insights for organizations. The company offers two main products: Element AssetHub and Element Unify. Element AssetHub integrates operational historian data with existing industrial systems, effectively managing the complexity and volume of real-time industrial data. Element Unify aligns information technology and operational technology by contextualizing industrial IoT data. The platform enables data and operations teams to automate data preparation, allowing for proactive decision-making and insights. Element Analytics' solutions focus on data standardization, contextualization, and assurance of data trust, as well as providing descriptive, diagnostic, and predictive analytics. The company, which was incorporated in 2014 and rebranded from Servature, Inc. in 2015, is based in San Francisco, California.

Castor Technologies

Seed Round in 2019
Castor Technologies, established in 2017 and based in Tel Aviv, Israel, specializes in developing 3D printing software. This software connects manufacturers with 3D printing capabilities, aiding them in evaluating how to integrate industrial 3D printing into their production processes. By offering a detailed technical and cost-saving analysis for an entire bill of materials, Castor empowers designers, new product introduction managers, and production engineers to make informed decisions when producing machine parts.

Modern Meadow

Series C in 2019
Modern Meadow, LLC is a biofabrication company based in Brooklyn, New York, that specializes in creating animal-free leather derived from living cells. Founded in 2011, the company operates at the intersection of material science and biology, utilizing its proprietary Bio-Alloy and Bio-Farm technologies to engineer sustainable materials. These innovations leverage tuned proteins to replace petrochemical and animal-derived inputs, ensuring high performance without compromising on quality. Modern Meadow's products are designed for immediate scalable adoption across various industries, including materials and beauty, and emphasize traceability from lab to brand. By focusing on fermentation-based bio-collagen and other protein applications, the company promotes environmental sustainability by significantly reducing greenhouse gas emissions, while maintaining the biological functions of materials for optimal quality and appearance.

Organic Meadow

Private Equity Round in 2019
Organic Meadow Inc. is an organic farmers' co-operative based in Guelph, Canada, specializing in the production and sale of organic dairy products. Established in 1989, the company offers a diverse array of items, including organic milk, cream, butter, yogurt, kefir, cream cheese, ice cream, sour cream, cheese, and cottage cheese. Additionally, Organic Meadow provides organic frozen vegetables such as green peas, sweet yellow corn, cut green beans, and mixed vegetables. Its products are distributed through retail stores across Canada. As of November 2015, Organic Meadow operates as a subsidiary of Meadowfresh Dairy Corporation.

Medvance

Series A in 2019
Medvance is a pioneer in the development of 3D printed medical implants, specifically using PEEK materials. The company specializes in creating medical 3D printing equipment and software tailored for advanced medical engineering. By providing innovative 3D printing solutions, Medvance aims to enhance medical outcomes for patients and healthcare professionals. Its strategic partnership with Evonik ensures a reliable supply of raw materials, further supporting Medvance's mission to deliver cutting-edge medical technologies. The company's initiatives are focused on improving healthcare in China and expanding its impact globally.

Structured Polymers

Acquisition in 2019
Structured Polymers is the world’s first colored ink manufacturer for industrial 3D printers. Their proprietary method utilizes large-scale textile techniques to create new and traditional polymers with significantly improved properties at lower costs and in larger quantities. One of the earliest developers of 3D printing, the inventor of SLS, and the design lead of the first commercial SLS system are just a few of the brightest minds on their team. They bring extensive mechanical engineering, material development, and startup expertise. They’ve set out to bring the properties of aluminum for the price of plastic. Let’s build something together.

Velox

Series B in 2018
Velox develops and manufactures industrial-grade direct-to shape digital decoration solutions for the rigid container industry. Their proprietary DTS-Inkjet technology, based on uniquely formulated inks and dedicated deposition architecture, introduces an entirely new approach to digital printing that is poised to disrupt the packaging decoration market. Their debut product is the Velox IDS 250 – the first industrial-grade digital decorator for mass production of cylindrical containers available on the market. It delivers superior decoration quality and capabilities that outstrip analog printing solutions, while allowing a more efficient and flexible production process and a low total cost of ownership (TCO). Velox is powered by an expert team with uniquely extensive and wide-ranging experience in digital printing. It is led by veteran executives with proven success in driving company growth.

PeroxyChem

Acquisition in 2018
PeroxyChem LLC is a manufacturer specializing in hydrogen peroxide and its derivatives, including peracetic acids, persulfates, and calcium peroxides. The company also offers mixed acids and remediation technologies. Founded in 2013 and based in Philadelphia, Pennsylvania, PeroxyChem serves a diverse range of industries such as environmental services, food and beverage, cleaning and sanitization, oil and gas production, polymer and chemical synthesis, electronics, pharmaceuticals, cosmetics, and pulp and paper. With a strong commitment to customer service and product quality, the company operates sales, research, and manufacturing facilities across North America, Europe, and Asia. In 2014, PeroxyChem transitioned from being a part of FMC Corporation to becoming an independent entity, later operating as a subsidiary of Evonik Industries AG. Its vision is to be the leading global supplier of oxidative solutions, driving innovation alongside adjacent technologies across its various industrial markets.

Porphyrio

Acquisition in 2018
Porphyrio NV, based in Leuven, Belgium, specializes in the development of advanced management systems for poultry farming. The company offers two primary products: Lay-Insight, which focuses on the management of egg production, and Broiler-Insight, designed for broiler production management. Porphyrio’s technology is tailored for various types of poultry, including breeders, laying hens, broilers, and turkeys. Its innovative systems leverage real-time data and advanced statistical algorithms to enhance operational efficiency and provide proactive early warnings, enabling farm managers to optimize their production processes. Additionally, Porphyrio’s solutions integrate access control, video surveillance, and connectivity with external enterprise resource planning systems, providing comprehensive support for livestock management. Since November 2018, Porphyrio has operated as a subsidiary of Evonik Industries AG, further solidifying its position in the agricultural technology sector.

In Ovo

Series A in 2018
In Ovo is a biotechnology company focused on enhancing animal welfare and operational efficiency within the poultry industry. It addresses a significant issue in hatcheries: the culling of male chicks shortly after hatching. The company has developed an innovative gender screening technology that utilizes biomarkers to identify the gender of embryos early in the breeding process. This solution alleviates the stress associated with traditional manual gender sorting, reduces energy consumption and carbon dioxide emissions in hatcheries, and eliminates the necessity to cull one-day-old male chicks. By improving animal welfare and promoting sustainability, In Ovo aims to transform the practices within the poultry sector while simultaneously increasing efficiency.

mySkin

Series A in 2018
mySkin, Inc. is a Jersey City-based company founded in 2007 that specializes in skin care technology and devices. It is known for developing the world's first transdermal skin analysis system, the dermograph™, which employs proprietary imaging technology to assess skin health. The company offers a range of products, including OKU, an anti-aging device and app aimed at improving skin appearance. In addition to its innovative devices, mySkin provides an extensive online platform for skin care products, featuring a curated selection of over one million items. Utilizing a patented algorithm, mySkin generates personalized product recommendations based on users' skin profiles, which consider genetics, lifestyle, and personal preferences. This approach fosters a collaborative community, allowing users to share experiences and find effective solutions for various skin concerns. The company is continuously working on new products to expand its offerings in the growing skin care market.

HPNow

Venture Round in 2017
HPNow is a company focused on developing innovative water and air treatment solutions through the on-site generation of hydrogen peroxide. Their technology allows for the efficient and autonomous production of hydrogen peroxide using only water, electricity, and air. With their compact HPGen hydrogen-peroxide generators, HPNow aims to replace conventional disinfectants, such as chlorine, which are increasingly regulated due to safety concerns. This transition not only enhances the safety of water, air, and food but also offers significant cost savings and logistical benefits for users. By providing a safer and eco-friendly alternative to toxic chemical disinfectants, HPNow seeks to reduce environmental impact while improving overall treatment efficacy across various industries.

Numaferm

Seed Round in 2017
NUMAFERM GmbH, based in Düsseldorf, Germany, specializes in the production of peptides through an innovative bioprocess that utilizes microorganisms to convert simple nutrients into peptides. Founded in 2017, the company offers a range of services including feasibility studies, custom synthesis, peptide development, upscaling, and licensing. NUMAFERM's unique manufacturing process significantly reduces production costs—potentially by up to 1000 times—making it a reliable platform for producing peptides of various sequences, lengths, and functionalities. This technology not only facilitates the discovery of peptides but also supports their commercial production, thereby unlocking the potential of peptides, proteins, and pepteins as valuable feedstock for various applications.

Dr. Straetmans

Acquisition in 2017
Dr. Straetmans is a company dedicated to researching and developing intelligent cosmetic solutions with over thirty years of expertise in the industry. It specializes in supplying and trading high-quality raw materials while also serving as a developer of innovative concepts and formulations tailored for the cosmetics sector. The company emphasizes the importance of individual well-being, focusing on manufacturing and stabilizing cosmetics using natural methods. Dr. Straetmans is committed to environmentally sound business practices and engages in continual dialogue with customers, suppliers, and employees. The firm is known for its development and marketing of alternative preservatives that promote humane, environmentally friendly practices in cosmetics production. With a strong focus on responsibility and collaboration, Dr. Straetmans strives to provide the best possible solutions for its clients.

Wiivv

Series A in 2017
Wiivv Wearables Inc. is a bionics company based in Vancouver, Canada, that specializes in custom 3D printed footwear and wearable gear. Utilizing advanced 3D-mapping technology accessible via a smartphone app, Wiivv designs its products, including insoles and sandals, to fit the unique anatomy of each customer. The company was founded in 2014, and it operates a manufacturing research and development center in San Diego, California. Wiivv's offerings are tailored for various types of footwear, such as running shoes, dress shoes, and casual footwear. The company also collaborates with brands and creators to enhance their product lines by leveraging its proprietary customization platform, which incorporates biomechanics research, computer vision, artificial intelligence, and machine learning to deliver on-demand, digitally manufactured products. All of Wiivv's innovations aim to improve comfort and support for users, helping them move more effectively.

Nanotech Industrial Solutions

Venture Round in 2017
Nanotech Industrial Solutions (NIS) specializes in the production of oil additives, metalworking fluids, industrial oils, and greases. The company utilizes patented technology to create spherical nanoparticles that enhance the performance of these products. NIS's additives significantly improve friction and wear properties while increasing the extreme pressure capacity, which leads to greater resource efficiency for heavy machinery, power plants, and industrial applications. By optimizing lubricants and formulations, NIS helps automotive businesses reduce downtime and improve operational efficiency, making a notable impact in the field of industrial lubrication solutions.

Huber - silica

Acquisition in 2016
Huber - silica is focused primarily on dental and life science applications.

Algal Scientific

Convertible Note in 2016
Algal Scientific Corporation, founded in 2009 and based in Plymouth, Michigan, specializes in the development and commercialization of algae-based products and technologies for various industries, including animal health, human nutrition, and water treatment. The company offers Algamune, a beta glucan derived from algae that enhances immune health in livestock and aquatic species, and AlgaGLUCAN, a similar product aimed at human nutraceuticals and functional foods. Additionally, Algal Scientific provides the Hypertrophic water treatment technology, which is designed to treat dissolved organics, nitrogen, and phosphorus in wastewater while generating a natural fertilizer byproduct. This technology serves customers in the food and beverage sector, including breweries, dairies, and meat producers, contributing to sustainable practices and resource conservation. The company also maintains an office in Beijing, China, to support its international operations.

Vivasure Medical

Series C in 2016
Vivasure Medical Limited is a medical device company based in Galway, Ireland, that specializes in the research, development, and manufacture of arterial and venous closure devices utilizing its patented PerQseal technology. The company focuses on creating polymer implants and delivery systems aimed at minimally invasive vessel closures, primarily in cardiology, interventional radiology, and vascular surgery. Its flagship product is an absorbable patch-based large-bore percutaneous closure device, designed to effectively close large arteriotomies resulting from transcatheter procedures, including transcatheter aortic valve replacement and endovascular aneurysm repair. Founded in 2008, Vivasure Medical is committed to advancing techniques that enhance patient outcomes in vascular access procedures.

Transferra Nanosciences

Acquisition in 2016
Transferra Nanosciences Inc. is a contract development and manufacturing organization based in Burnaby, Canada, specializing in the development and production of complex drug delivery systems utilizing lipid nanoparticle technology. Established in 1991, the company offers a range of services to biotechnology and pharmaceutical companies, including prototype identification, scale-up, process development, and GMP batch manufacturing for IND toxicology studies and human clinical trials. Transferra Nanosciences focuses on lipid nanoparticle-based formulations such as liposomes and micelles, providing comprehensive GMP manufacturing services that encompass raw material acquisition, method development, compounding, and quality testing. The company also offers analytical tech transfer and stability testing for various product types, including small molecules, peptides, and proteins. With a client base spanning North America and international markets, Transferra Nanosciences continues to support the advancement of pharmaceutical products.

Alkion Biopharma

Acquisition in 2016
Alkion Biopharma SAS is a biopharmaceutical company based in Evry, France, established in 2011. The company specializes in the identification, validation, manufacture, and commercialization of treatments for cancer, particularly targeting multidrug resistant (MDR) cancers. Utilizing its proprietary AlkaBurst technology, Alkion Biopharma produces plant-based active ingredients and recombinant proteins for various therapeutic applications. As of May 2016, it operates as a subsidiary of Evonik Industries AG.

MedPalett

Acquisition in 2016
MedPalett specializes in food ingredients containing anthocyanins, known for their natural antioxidant properties. Medpalett operates as a subsidiary of Evonik Industries.

Synoste

Venture Round in 2016
Synoste Oy, founded in 2007 and based in Espoo, Finland, specializes in innovative medical solutions for correcting skeletal deformities. The company focuses on developing a third-generation limb-lengthening system aimed at improving the conventional, often uncomfortable, procedures associated with bone-lengthening and deformation correction. By leveraging smart materials, Synoste’s technology aims to provide a less painful experience for patients while enhancing the precision and control of the treatment process. This approach not only reduces complication rates but also facilitates a quicker recovery, allowing patients to return to their normal activities sooner. Operating as a subsidiary of Globus Medical, Inc., Synoste addresses various conditions, including congenital and trauma-related limb discrepancies, as well as craniomaxillofacial deformations.

Wiivv

Seed Round in 2015
Wiivv Wearables Inc. is a bionics company based in Vancouver, Canada, that specializes in custom 3D printed footwear and wearable gear. Utilizing advanced 3D-mapping technology accessible via a smartphone app, Wiivv designs its products, including insoles and sandals, to fit the unique anatomy of each customer. The company was founded in 2014, and it operates a manufacturing research and development center in San Diego, California. Wiivv's offerings are tailored for various types of footwear, such as running shoes, dress shoes, and casual footwear. The company also collaborates with brands and creators to enhance their product lines by leveraging its proprietary customization platform, which incorporates biomechanics research, computer vision, artificial intelligence, and machine learning to deliver on-demand, digitally manufactured products. All of Wiivv's innovations aim to improve comfort and support for users, helping them move more effectively.

JeNaCell

Series A in 2015
JeNaCell GmbH, founded in 2012 and based in Jena, Germany, specializes in biotechnology, focusing on the development and manufacture of bio-technologically derived cellulose. The company has created a patented technology for the continuous production of high-performance biomaterials featuring natural nanostructures. This innovative nano cellulose is characterized by its defined shape and controllable structural design, allowing clients to develop advanced products in medicine, cosmetics, technology, and pharmaceuticals. JeNaCell's offerings aim to enhance skin protection, particularly in the treatment of chronic wounds, and support applications in laser treatments and aesthetic dermatology.

Monarch catalyst Pvt.

Acquisition in 2015
Monarch Catalyst Pvt. Ltd. (MCPL) is an established manufacturer of Nickel Catalyst for oils & oleo chemicals in India since 1973. It was the brain-child of two technocrats, who converted their dream into reality. The operations are based in Dombivli, near Mumbai, India. In a short period of time, MCPL has been instrumental in bringing together a large number of intellectual minds with international exposure and creating an innovative atmosphere in the area of catalysts.

Algal Scientific

Series B in 2015
Algal Scientific Corporation, founded in 2009 and based in Plymouth, Michigan, specializes in the development and commercialization of algae-based products and technologies for various industries, including animal health, human nutrition, and water treatment. The company offers Algamune, a beta glucan derived from algae that enhances immune health in livestock and aquatic species, and AlgaGLUCAN, a similar product aimed at human nutraceuticals and functional foods. Additionally, Algal Scientific provides the Hypertrophic water treatment technology, which is designed to treat dissolved organics, nitrogen, and phosphorus in wastewater while generating a natural fertilizer byproduct. This technology serves customers in the food and beverage sector, including breweries, dairies, and meat producers, contributing to sustainable practices and resource conservation. The company also maintains an office in Beijing, China, to support its international operations.

Nanocomp

Venture Round in 2015
Nanocomp is a privately-held high-technology company founded in 1997, specializing in the manufacturing of micro- and nanophotonics products. The company focuses on producing nano-optical structures imprinted on polymer films, which cater to various applications in the consumer electronics, laser sensing, and special lighting sectors. Utilizing a reel-to-reel production process, Nanocomp achieves efficient mass production of its film optics, allowing clients to benefit from cost-effective and time-efficient solutions. Through its innovative approach, Nanocomp positions itself as a key player in the advancement of optical systems and related technologies.

Biosynthetic Technologies

Venture Round in 2014
Biosynthetic Technologies, LLC is a manufacturer of bio-based synthetic oils derived from organic fatty acids found in plant oils, catering to the lubricant, specialty chemical, and cosmetic industries. The company produces a diverse range of biosynthetic base oils suitable for applications such as passenger car motor oils, marine lubricants, hydraulic fluids, and food-grade lubricants, among others. These oils are designed to outperform traditional petroleum-based products while being sustainable, biodegradable, and non-toxic. Founded in 2004 and headquartered in Irvine, California, with a production facility in Baton Rouge, Louisiana, Biosynthetic Technologies holds a robust portfolio of patents protecting its innovative biosynthetic formulations.

FRX Innovations

Series C in 2014
FRX Innovations is an industrial manufacturer based in Chelmsford, MA, specializing in environmentally sustainable flame retardant solutions within the plastics and additives market. The company produces Nofia polyphosphonates, a family of non-halogen, transparent, and high melt flowing fire-resistant plastics. FRX Innovations focuses on delivering high value-added solutions to various sectors, including textiles, electronics, automotive, electric vehicles, and medical devices. Its products are developed using sustainable green chemistry principles, featuring a solvent-free production process that generates no waste byproducts and maximizes atom efficiency. Through its innovative offerings, FRX Innovations aims to address the growing demand for safer and more sustainable materials in multiple industries.

Algal Scientific

Series A in 2014
Algal Scientific Corporation, founded in 2009 and based in Plymouth, Michigan, specializes in the development and commercialization of algae-based products and technologies for various industries, including animal health, human nutrition, and water treatment. The company offers Algamune, a beta glucan derived from algae that enhances immune health in livestock and aquatic species, and AlgaGLUCAN, a similar product aimed at human nutraceuticals and functional foods. Additionally, Algal Scientific provides the Hypertrophic water treatment technology, which is designed to treat dissolved organics, nitrogen, and phosphorus in wastewater while generating a natural fertilizer byproduct. This technology serves customers in the food and beverage sector, including breweries, dairies, and meat producers, contributing to sustainable practices and resource conservation. The company also maintains an office in Beijing, China, to support its international operations.

Silbond

Acquisition in 2014
Silbond Corp. is a supplier and manufacturer of silicic acid esters, primarily focusing on tetra ethyl ortho silicate (TEOS). The company caters to various industries, including semiconductors, coatings, foundry, and chemicals, providing essential products for a wide range of applications. Its clientele comprises semiconductor industry aggregators, coatings manufacturers, investment casting foundries, and chemical processors. As a subsidiary of Evonik Industries, Silbond Corp. operates both in the United States and internationally, emphasizing its role in delivering specialized solutions to meet the diverse needs of its customers.

FRX Innovations

Series C in 2014
FRX Innovations is an industrial manufacturer based in Chelmsford, MA, specializing in environmentally sustainable flame retardant solutions within the plastics and additives market. The company produces Nofia polyphosphonates, a family of non-halogen, transparent, and high melt flowing fire-resistant plastics. FRX Innovations focuses on delivering high value-added solutions to various sectors, including textiles, electronics, automotive, electric vehicles, and medical devices. Its products are developed using sustainable green chemistry principles, featuring a solvent-free production process that generates no waste byproducts and maximizes atom efficiency. Through its innovative offerings, FRX Innovations aims to address the growing demand for safer and more sustainable materials in multiple industries.

SurModics Pharmaceuticals

Acquisition in 2011
SurModics Pharmaceuticals designs and produces bio-resorbable polymers (marketed under the brand Lakeshore Biomaterials™) and possesses expertise and facilities to carry out all phases of pharmaceutical product development up to commercial manufacturing. The business focuses on the development of injectable drug delivery systems that systemically or locally release active pharmaceutical ingredients (API) within a period of up to several months. Formulation approaches include bio-resorbable microparticles, nanoparticles, liposomes, implants and other polymer-based configurations.

Hanse Chemie Group

Acquisition in 2011
Hanse Chemie Group produces high-quality components and raw materials for the manufacture of products such as sealants, adhesives, and molding and casting compounds.

H.C. Starck-catalyst business

Acquisition in 2010
H.C. Starck develops, produces, and markets metallic and ceramic powders, and fabricated products.

Membrane Extraction Technology

Acquisition in 2010
Membrane Extraction Technology is a London-based chemical separations specialist supplying the pharmaceutical and fine chemicals industries.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.